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Abstract
Nicotine replacement therapy (NRT) is currently recommended as a safe smoking cessation aid for pregnant women.
However, fetal and neonatal nicotine exposure in rats causes mitochondrial-mediated beta cell apoptosis at weaning, and
adult-onset dysglycemia, which we hypothesize is related to progressive mitochondrial dysfunction in the pancreas.
Therefore in this study we examined the effect of fetal and neonatal exposure to nicotine on pancreatic mitochondrial
structure and function during postnatal development. Female Wistar rats were given saline (vehicle control) or nicotine
bitartrate (1 mg/kg/d) via subcutaneous injection for 2 weeks prior to mating until weaning. At 3–4, 15 and 26 weeks of
age, oral glucose tolerance tests were performed, and pancreas tissue was collected for electron microscopy, enzyme
activity assays and islet isolation. Following nicotine exposure mitochondrial structural abnormalities were observed
beginning at 3 weeks and worsened with advancing age. Importantly the appearance of these structural defects in nicotine-
exposed animals preceded the onset of glucose intolerance. Nicotine exposure also resulted in significantly reduced
pancreatic respiratory chain enzyme activity, degranulation of beta cells, elevated islet oxidative stress and impaired
glucose-stimulated insulin secretion compared to saline controls at 26 weeks of age. Taken together, these data suggest
that maternal nicotine use during pregnancy results in postnatal mitochondrial dysfunction that may explain, in part, the
dysglycemia observed in the offspring from this animal model. These results clearly indicate that further investigation into
the safety of NRT use during pregnancy is warranted.
Citation: Bruin JE, Petre MA, Raha S, Morrison KM, Gerstein HC et al. (2008) Fetal and Neonatal Nicotine Exposure in Wistar Rats Causes Progressive Pancreatic
Mitochondrial Damage and Beta Cell Dysfunction. PLoS ONE 3(10): e3371. doi:10.1371/journal.pone.0003371
Editor: Adrian Vella, Mayo Clinic College of Medicine, United States of America
Received July 9, 2008; Accepted September 16, 2008; Published October 8, 2008
Copyright:  2008 Bruin et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding for this project was provided by the Canadian Institutes of Health Research (MOP 86474) to Drs. Holloway and Morrison. Ms. Bruin was funded
by an Ontario Women’s Health Council/CIHR Institute of Gender and Health Doctoral research award and a CIHR Strategic Training Program in Tobacco Research
Fellowship. Both Ms. Bruin and Ms. Petre were supported by an Ashley Studentship for Research in Tobacco Control. Dr. Gerstein holds the Population Health
Institute Chair in Diabetes Research (sponsored by Aventis). Dr. Raha was provided salary support by Mr. Warren Lammert and Ms. Kathy Corkins and the Hamilton
Health Sciences Foundation. We thank the staff of the McMaster University Central Animal Facility, Ms. Jillian Hyslop and Ms. Lisa Kellenberger for their assistance
with the animal work and the staff of the McMaster University Electron Microscopy Facility for their excellent technical support with the EM analysis.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hollow@mcmaster.ca
Introduction
Cigarette smoking is associated with numerous adverse
obstetrical and fetal outcomes [1–6], yet 15–20% of women
reportedly smoke during pregnancy [1,7]. Furthermore, mounting
epidemiologic evidence indicates that maternal smoking is
associated with an increased risk of obesity, hypertension and
type 2 diabetes in the offspring [7–13], although the mechanisms
underlying this relationship are unknown. Our laboratory has
previously demonstrated in a rat model that maternal exposure to
nicotine, the major addictive component of cigarettes, during
pregnancy and lactation results in postnatal obesity and impaired
glucose homeostasis in adult offspring [14,15]. Because nicotine
replacement therapy (NRT) is recommended for pregnant women
who cannot quit smoking by other means [16], these results may
have significant public health implications. In our animal model,
postnatal dysglycemia following fetal and neonatal nicotine
exposure was associated with a loss of beta cell mass, beginning
at birth and persisting into adulthood [14]. This reduction in beta
cell mass following developmental nicotine exposure may partially
explain the increased risk of type 2 diabetes in the offspring of
women who smoked during pregnancy [8].
Individuals with type 2 diabetes are unable to produce sufficient
insulin to maintain normal glucose homeostasis [17]. This has
been attributed, in part, to reduced beta cell mass and impaired
beta cell function [17,18]. In beta cells, the mitochondria are
involved in triggering apoptosis, thereby contributing to the
regulation of beta cell mass [19,20]. We have previously shown
that fetal and neonatal exposure to nicotine results in beta cell loss
due to increased oxidative stress [21] and beta cell apoptosis
[14,15]. Furthermore, we have demonstrated that this nicotine-
induced oxidative stress differentially targeted the mitochondria in
the pancreas [21], resulting in mitochondrial-mediated beta cell
apoptosis [22]. However, in addition to regulating beta cell mass
(via apoptosis), the mitochondria are also critical for maintenance
of beta cell function through the coupling of a glucose stimulus to
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3371insulin release [23–25]. Both human and animal studies have
demonstrated mitochondrial dysfunction in islets of subjects with
type 2 diabetes [26,27]. Therefore, we hypothesize that the
dysglycemia observed in this animal model following fetal and
neonatal nicotine exposure is likely mediated by pancreatic
mitochondrial defects. This study will examine the effect of fetal
and neonatal exposure to nicotine on postnatal mitochondrial
structure and function, as well as subsequent beta cell function.
Methods
Maintenance and treatment of animals
All animal experiments were approved by the Animal Research
Ethics Board at McMaster University, in accordance with the
guidelines of the Canadian Council for Animal Care. Nulliparous
200–250 g female Wistar rats (Harlan, Indianapolis, IN, USA) were
maintained under controlled lighting (12:12 L:D) and temperature
(22uC) with ad libitum access to food and water. Dams were
randomly assigned (n=30 per group) to receive saline (vehicle) or
nicotine bitartrate (1 mg?kg
21?d
21, Sigma-Aldrich, St. Louis, MO,
USA) via subcutaneous injection daily for 2 weeks prior to mating
until weaning (postnatal day 21). We have previously demonstrated
that this dose of nicotine (1 mg?kg
21?d
21) results in cotinine
concentrations in maternal serum that are similar to ‘‘moderate’’
female smokers and in nicotine-exposed offspring serum at birth
that are comparable to infants nursed by smoking mothers [28]. At
postnatal day 1, litters were culled to eight to assure uniformity of
litter size between treated and control litters. To eliminate any
confounding effects of the female reproductive cycle, only male
offspring were used in this study.
Oral glucose tolerance
Glucose homeostasis was investigated in nicotine-exposed and
saline control rats at 4, 15 and 26 weeks of age (n=15 per group)
using sequential oral glucose tolerance tests (OGTT) as previously
described [14,15]. Briefly, after an overnight fastinsulinand glucose
were measured in saphenous vein samples, collected by repeated
puncture, at baseline, 30 and 120 minutes after rats were given
2g ?kg
21 glucose (Sigma-Aldrich, St. Louis, MO, USA) in water by
gavage. Blood samples were allowed to clot at 4uC, centrifuged and
stored at 280uC until assayed. Serum glucose concentrations were
measured by a commercially available kit using the glucose oxidase
method (Pointe Scientific Inc., Canton, MI, USA), and insulin levels
were measured by an ultra sensitive rat insulin ELISA (Crystal
Chem Inc., Downers Grove, IL, USA). Data are presented as the
average areaunder the curve (AUC)6SEM for saline-and nicotine-
exposed offspring at each age.
Electron microscopy
Pancreas tissue from offspring at 3 weeks (n=4 per group),
15 weeks (saline: n=3 and nicotine: n=4), and 26 weeks (n=3
per group) were collected and processed for electron microscopy as
previously described [22]. All chemicals used for electron
microscopy were purchased from Canemco Inc., Montreal, QC,
Canada unless otherwise stated. Thick sections (approximately
1 mm) were cut on an Ultracut E ultramicrotome (Leica
Microsystems, Wetzlar, Germany), stained with toluidine blue
and examined under a light microscope to ensure the presence of
islets. Thin sections (approximately 70 nm) were then cut from
areas of the tissue containing islets, mounted on a Cu/Pd grid (200
mesh), and stained with saturated uranyl acetate and lead citrate.
Grids were examined with a JEOL 1200EX transmission electron
microscope (JEOL Ltd., Tokyo, Japan) and representative
photographs were taken at either 50006 or 120006 magnifica-
tion. All photographs were analysed by a single investigator
blinded to the treatment groups using Image Pro Plus Version 5.1
software (Media Cybernetics, Inc., Silver Spring, MD, USA).
Beta cells were identified within the pancreas sections by the
presence of insulin granules. Insulin granules were classified as
filled (dense-core), immature (light gray granule) or empty (no
insulin). The number of insulin granules and mitochondria were
calculated relative to the area of a beta cell. Individual
mitochondrial morphology was assessed by quantifying: a) the
average mitochondrion area; b) the proportion of mitochondria
with blebbing and/or merging with other mitochondria (refer to
Figure 1E for examples); c) the proportion of mitochondria in each
of five defined stages of progressive deterioration. The definitions
for each mitochondrial stage were created using a modification of
a previously described scale for assessing mitochondrial morphol-
ogies [29]. Stage 1 mitochondria were classified as structurally
healthy, with dense, intact cristae. Stage 2 mitochondria had
visible swelling, but maintained distinctive intact cristae structure.
Stage 3 mitochondria had more severe swelling and minimal
evidence of intact cristae. Stage 4 mitochondria displayed severe
swelling, minimal cristae structure and formation of vacuoles.
Stage 5 mitochondria were extremely large and swollen, with
essentially complete loss of defined structure within the mitochon-
drial membrane. An example of mitochondria at each defined
morphological stage is provided in Figure 2F.
Mitochondrial enzyme activity
Pancreas tissue was excised from offspring at 3 weeks (saline:
n=7, nicotine: n=5), 15 weeks (n=5 per group) and 26 weeks
(n=5 per group), frozen on dry ice and stored at 280uC until
analysis. Tissue samples were homogenized in homogenization
buffer (5 mM HEPES pH 7.4, 100 mM KCl, 70 mM sucrose,
220 mM mannitol, 1 mM EGTA) with Complete Mini EDTA-
free protease inhibitors (Roche Applied Science, Laval, QC,
Canada) using Tenbroeck tissue grinders. Homogenates were spun
for 10 min at 6006g, the supernatant removed, flash frozen in
liquid nitrogen and stored at 280uC until use. Citrate synthase
activity (an indicator of total mitochondrial mass) was measured
using the thiol reagent 5,59-dithio-bis-(2-nitrobenzoic acid)
(DTNB, Sigma Chemical Co., St. Louis, MO, USA). Complex
IV (cytochrome c oxidase) activity was assessed by measuring the
rate of cytochrome c (from equine heart; Sigma Chemical Co., St.
Louis, MO, USA) oxidation. Both activity assays were performed
using UV-spectrophotometry (Varian Inc., Palo Alto, CA, USA) as
previously described [30]. Data are expressed as the mean enzyme
activity relative to the wet weight of tissue.
Islet isolation
Islet isolation was performed as previously described [21] at
26 weeks of age. Briefly, the pancreas was immediately excised
following sacrifice, minced finely and placed in 6 mL of Hank’s
balanced salt solution (HBSS) (HyClone, Logan, UT, USA)
containing 4 mg/mL collagenase type IA (Sigma-Aldrich, St.
Louis, MO, USA), 100 IU/mL penicillin G and 0.25 mg/mL
streptomycin (Gibco, Grand Island, NY, USA). Following an
incubation period of 40 min at 37uC, the reaction was quenched
with 20 mL HBSS supplemented with 10% fetal bovine serum
(FBS) (HyClone, Logan, UT, USA), 100 IU/mL penicillin G and
0.25 mg/mL streptomycin. Islets were manually picked from the
suspension using a small glass pipette and a dissecting microscope.
The islets were incubated at 37uC, 5% CO2 /95% normal
atmosphere in 5 mL RPMI 1640 with 3.0 mM glucose (Life
Technologies, Burlington, ON, Canada) supplemented with 10%
Nicotine and the Mitochondria
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Reactive oxygen species production by isolated islets
Reactive oxygen species (ROS) production by isolated islets
following saline and nicotine exposure was measured using 29,79-
dichlorodihydrofluorescein diacetate (H2DCFDA) (Molecular
Probes Inc., Eugene, OR, USA) fluorescence as previously
described [21]. Since islet ROS production at weaning has been
previously confirmed in this animal model [21], oxidative stress
was only assessed at the endpoint of the current study (26 weeks).
Briefly, 80 islets from saline- and nicotine-exposed offspring (n=6
per group) were washed with PBS. Following centrifugation, the
supernatant was removed and the pelleted islets were then
resuspended in 100 mL of PBS containing 100 mMH 2DCFDA
and incubated for 3 h at 37uC. Because of the relatively low
number of cells in this assay, a long incubation period allows for
the diffusion of the oxidized dye from inside the cell back out into
Figure 1. Mitochondrial morphology during postnatal development. A) The number of mitochondria per beta cell area; B) individual
mitochondrion area; and C) percentage of mitochondria with blebbing and/or merging with a neighboring mitochondria from offspring at 3, 15 and
26 weeks of age following exposure to either saline or nicotine during fetal and neonatal development. Representative electron microscopy
photographs are provided to illustrate: D) typical mitochondrial structure (indicated by striped arrows) in the beta cells of saline and nicotine-
exposed offspring during postnatal development, and E) examples of mitochondrial blebbing and merging (indicated by solid black arrows);
N=nucleus. All data are presented as the mean6SEM. Values with an asterisk are significantly different from the saline control (p,0.05).
doi:10.1371/journal.pone.0003371.g001
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validated to determine ROS production by isolated islet cells in
rats [21,27]. In addition, since H2DCFDA must be made fresh
immediately prior to use, islets isolated on different days were
incubated in different batches of reagent. To account for day-to-
day variability within the experiment, a 43 mM hydrogen peroxide
reaction was prepared with each batch of H2DCFDA to calibrate
the performance of the dye. The hydrogen peroxide was added to
100 mMH 2DCFDA and incubated in parallel with the islet
reactions. Following the incubation period, the islets were
vigorously disrupted to release intracellular H2DCFDA. Both the
islet suspensions and the hydrogen peroxide control were
centrifuged, and the supernatants were transferred to black 96-
well plates (BD Falcon, Mississauga, ON, Canada). Fluorescence
of the 29,79-dichlorofluorescein product was determined using a
SpectaMax Gemini XS (Molecular Devices Corp., Sunnyvale,
CA, USA) microplate spectrofluorometer at excitation and
emission wavelengths of 505 nm and 540 nm, respectively. All
measurements of islet ROS production were normalized to the
43 mM hydrogen peroxide control and expressed as a percentage
of the average saline control.
Oxyblot detection of protein carbonyls in isolated islets
To assess oxidative damage by reactive oxygen species to islet
proteins, the presence of protein carbonyl groups was quantified
using the OxyBlot
TM Protein Oxidation Detection Kit (Chemicon
International, Temecula, CA, USA). Formation of protein
carbonyl groups was measured at 26 weeks in isolated pancreatic
islets (saline: n=6, nicotine: n=5). 100 islets were hand-picked
into eppendorf tubes and centrifuged for 3 minutes at 300 rcf. The
supernatant was removed and islets were resuspended in 100 mL
of homogenization buffer with protease inhibitors (as described
above) and frozen at 280uC until use. Upon thawing, cells were
lysed using a sonication probe. Protein samples (5 mL) were then
prepared with the Oxyblot
TM Kit, according to manufacturer’s
instructions. Derivatized protein was subjected to SDS-PAGE
using a 12 % separating gel and then electro-transferred to PVDF
blotting membrane (BioRad Laboratories, Hercules, CA, USA).
Membranes were blocked for 2 h at room temperature with 5 %
(w/v) skim milk in TBST (TBS, 0.5% (v/v) Tween 20), incubated
overnight at 4uC in rabbit-DNP antibody (1:150), and finally 1 h
at room temperature in secondary goat anti-rabbit IgG (HRP-
conjugated; 1:300). Blots were washed thoroughly in TBST
followed by TBS after immunoblotting. Reactive protein was
detected with ECL Plus chemiluminescence (Amersham Biosci-
ences, Piscataway, NJ, USA) and Bioflex X-ray film (Clonex
Corporation, Markham, ON, Canada). Densitometric analysis of
immunoblots was performed using ImageJ 1.37 v software
(National Institutes of Health, Bethesda, MD, USA); all proteins
were quantified relative to a Ponceau S (Sigma Aldrich, St. Louis,
MO, USA) loading control.
Glucose-stimulated insulin secretion in isolated islets
Glucose stimulated insulin secretion (GSIS) was examined as a
marker of beta cell function at 26 weeks of age. Briefly, 20 islets
from both saline- and nicotine-exposed offspring (n=6 per group)
were incubated in 100 mL of Krebs Ringer Bicarbonate buffer,
pH 7.4 (135 mM NaCl, 3.6 mM KCl, 5 mM NaHCO3, 0.5 mM
NaH2PO4?2H2O, 0.5 mM MgCl2?6H2O, 1.5 mM CaCl2?2H2O,
10 mM Hepes, 0.1% BSA) with either 3.0 mM glucose (basal) or
16.7 mM glucose (stimulated) for 2 hours at 37uC. All reactions
were performed in duplicate. Following the incubation, islets were
centrifuged, the media removed and stored at 280uC until use.
The pelleted islets were resuspended in 25 mL of cell homogeni-
zation buffer (as described above), sonicated to release insulin and
frozen at 280uC until use. Insulin levels were measured in both
the media and the pellet by an ultra sensitive rat insulin ELISA
(Crystal Chem Inc., Downers Grove, IL, USA). Results were
expressed as the concentration of insulin in the media relative to
the concentration remaining in the pellet, to normalize for
variability in the size of islets. Glucose-stimulated insulin release
was determined by comparing the amount of insulin released from
the pellet into the media at 16.7 mM glucose relative to 3 mM
glucose.
Statistical analysis
All statistical analyses were performed using SigmaStat (v.3.1,
SPSS, Chicago, IL, USA). The results are expressed as mean6
SEM. Data were checked for normality and equal variance and
were tested using unpaired Student’s t-tests (a=0.05) at each age.
Where data failed normality or equal variance test, data was
reanalyzed using Mann-Whitney rank sum test.
Results
Oral glucose tolerance tests
At 4 weeks of age there was no effect of nicotine exposure
(p.0.05) on the total glucose response (area under the curve;
AUC) to the oral glucose load. By 15 weeks of age the nicotine-
exposed animals had a higher total glucose response (AUC)
relative to the saline controls (p,0.05), an effect which was also
evident at 26 weeks of age (Figure 3).
Mitochondrial structure
There was no difference in the number of mitochondria per
beta cell area at any age (Figure 1A), but the mean individual
mitochondrion area was significantly higher (p,0.05) following
nicotine exposure at 15 and 26 weeks of age (Figure 1B) compared
to saline controls. Furthermore, the proportion of mitochondria
with either blebbing or merging with neighboring mitochondria
dramatically increased in the nicotine-, but not saline-exposed
animals with age (Figure 1C).
Structural abnormalities were also evident in mitochondria of
nicotine-exposed offspring starting at weaning (postnatal day 21).
At all ages, more than 75% of the mitochondria from saline-
exposed offspring were classified as stage 1 (structurally intact;
Figure 2A). In contrast, nicotine-exposed offspring had a
significant decrease in the proportion of healthy, stage 1
mitochondria beginning at 3 weeks of age, followed by a continual
decline with age, such that by 26 weeks only 31% of nicotine-
exposed mitochondria were classified as stage 1 (Figure 2A).
Coinciding with the loss of healthy stage 1 mitochondria was a
significant 4.7-fold increase in the proportion of stage 2
mitochondria (visible swelling) at 3 weeks in the nicotine-exposed
offspring (Figure 2B). Furthermore, by 15 weeks of age nearly 20%
of the mitochondria in beta cells of nicotine-exposed offspring
Figure 2. Stages of mitochondrial health during postnatal development. The percentage of mitochondria within beta cells at: A) stage 1, B)
stage 2, C) stage 3, D) stage 4, and E) stage 5. F) Electron microscopy images with examples of mitochondria at each of the five morphological
stages. d indicates that statistical analysis was not performed on these data due to lack of variability in the saline treatment group replicates. All data
are presented as mean6SEM.
doi:10.1371/journal.pone.0003371.g002
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proportion had increased to 57% (Figure 2C–E). In contrast, at all
ages examined less than 1% of the mitochondria from the saline
control group were at stages 3, 4 and 5 combined (Figure 2C–E). It
was not possible to perform statistics on the data presented in
Figures 2C, D or E due to lack of variability in the saline treatment
group replicates (nearly all 0%).
Mitochondrial enzyme activity
By 26 weeks, complex IV activity (a marker of mitochondrial
function) was significantly reduced in the nicotine-exposed animals
compared to saline controls (p,0.05; Figure 4A). There was no
difference in citrate synthase activity (an indicator of mitochon-
drial mass) in the pancreas at any age examined (p.0.05;
Figure 4B).
Insulin granule characteristics
By 26 weeks of age, the nicotine-exposed animals had 32%
fewer insulin granules in total (p,0.05; Figure 5A) and an 86%
reduction in the number of immature granules per beta cell area
(p,0.05; Figure 5B). The number of filled insulin granules per
beta cell area was lower at all ages examined following nicotine
exposure, but did not reach statistical significance (p.0.05;
Figure 5C).
Oxidative stress
Islet ROS production in adult animals at 26 weeks of age was
increased by approximately 20% following fetal and neonatal
exposure to nicotine relative to saline (p,0.05; Figure 6).
Furthermore, there was a 35% increase in the formation of
protein carbonyl groups in the islets of nicotine-exposed offspring
compared to saline controls (p,0.05; Figure 6).
Glucose-stimulated insulin secretion
Fetal and neonatal exposure to nicotine resulted in impaired
GSIS from pancreatic islets isolated from 26 week old animals
(Figure 7).
Discussion
Results from this study clearly demonstrate that fetal and
neonatal nicotine exposure alters both mitochondrial structure and
function postnatally. Mitochondrial structural abnormalities are
observable prior to the onset of glucose intolerance and
progressively worsen with age even though nicotine exposure is
discontinued at weaning. Furthermore, as nicotine-exposed
animals age, the observed mitochondrial defects appear to impact
both mitochondrial function and beta cell function. These data
raise concerns about the long term health consequences to the
offspring following cigarette smoking or nicotine replacement
therapy use during pregnancy and lactation.
The first observable mitochondrial alteration following devel-
opmental nicotine exposure was abnormal mitochondrial ultra-
structure in the neonates at weaning (3 weeks of age). These early
structural alterations in the nicotine-exposed offspring coincided
with increases in both pancreatic oxidative stress [21] and
mitochondrial-mediated beta cell apoptosis [22]. However, these
changes in mitochondrial structure precede any observable
alterations in glucose homeostasis. As the nicotine-exposed
animals age, the proportion of beta cell mitochondria with severe
structural abnormalities of the inner membrane (stages 3–5) and
outer membrane (indicated by blebbing and/or merging)
increased dramatically, despite discontinuation of nicotine expo-
sure at weaning. These profound structural defects were not
associated with any changes to the number of mitochondria within
the beta cells, but were accompanied by a modest decline in
mitochondrial enzyme activity, degranulation of beta cells,
decreased beta cell function and impaired glucose tolerance
(IGT). Therefore, we suggest that nicotine-induced mitochondrial
damage has a significant role in the development of glucose
intolerance in this animal model.
It is estimated that 98% of the energy for the beta cell is
produced by mitochondrial oxidative metabolism [25]. Mitochon-
dria are essential for both stages of glucose-stimulated insulin
secretion from beta cells, including glucose entry and metabolism,
as well as insulin exocytosis [25,31]. In this study, fetal and
neonatal nicotine exposure resulted in reduced complex IV
enzyme activity at 26 weeks of age, an effect that was not
associated with loss of mitochondrial number or mass. Since the
respiratory chain enzymes are located within the inner membrane
of the mitochondria, impairment of complex IV activity was
expected given the observed deterioration of the inner membrane
structural integrity in this animal model following perinatal
nicotine exposure. Conversely, we did not detect a change in
citrate synthase activity. However, citrate synthase is located
within the mitochondrial matrix and therefore does not depend on
Figure 3. Oral glucose tolerance tests during postnatal development. Area under the curve (AUC) for the total glucose response to an oral
glucose challenge at 4, 15 and 26 weeks of age in saline (closed circles) and nicotine-exposed (open circles) animals. All data are presented as
mean6SEM. Values with an asterisk are significantly (p,0.05) different from saline controls.
doi:10.1371/journal.pone.0003371.g003
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synthase is an indicator of mitochondrial mass, a decline in activity
would only be expected if nicotine exposure resulted in a reduction
in the number of mitochondria.
We propose that exposure of the beta cell mitochondria to
reactive oxygen species (ROS) likely contributed to the loss of
respiratory enzyme function and mitochondrial structural integrity
in this animal model. ROS have been shown to inactivate the iron-
sulfur centers of the electron transport chain complexes, thus
causing defects in mitochondrial energy production [32]. In
addition, when the function of one of the electron carrier
complexes is impaired electrons are not shuttled properly through
the electron transport chain (ETC) and are increasingly lost to
molecular oxygen, resulting in increased ROS formation [19]. We
hypothesize that in our animal model, this cycle was initiated
during fetal and neonatal exposure to nicotine, a compound
shown to have pro-oxidant properties in vitro and in vivo [33–35].
We have previously demonstrated that nicotine exposure during
fetal and neonatal development leads to increased islet ROS
production and oxidative damage at weaning [21]. We propose
that this nicotine-induced increase in ROS likely triggered early,
but undetectable damage to the ETC enzymes, thus initiating a
feed-forward chain of progressive mitochondrial damage and
additional ROS production. Furthermore, once dysglycemia has
been established (by 15 weeks of age in the current study), chronic
high glucose levels likely also contributed to the observed
deterioration of pancreatic mitochondrial structure and function,
as well as the loss of beta cell function. Chronic exposure to high
glucose has previously been shown to induce mitochondrial-
mediated beta cell apoptosis [36], as well as mitochondrial
superoxide production and beta cell dysfunction in isolated islets
[37]. As predicted, during adulthood nicotine-exposed offspring
had elevated islet ROS production that was associated with
increased formation of protein carbonyl groups in isolated islets,
an indication that the redox balance has been disrupted in these
cells. Therefore, in this animal model, perinatal nicotine exposure
increases islet ROS production both at the end of lactation (i.e.
during the nicotine exposure) [21] prior to the observable changes
in ETC enzyme activity, and at 26 weeks of age when impaired
complex IV activity and the most pronounced mitochondrial
structural abnormalities were observed. We predict that the early
mitochondrial structural alterations are likely initiated by nicotine-
induced ROS, whereas the dramatic worsening of these defects
between 15 and 26 weeks may be a consequence of chronic
exposure to high glucose combined with ROS production by
previously damaged mitochondrial ETC enzymes.
Although only a subtle reduction in respiratory enzyme activity
was detected in the whole pancreas at 26 weeks following nicotine
Figure 4. Mitochondrial enzyme activity during postnatal development. A) Complex IV enzyme activity (an indicator of mitochondrial
electron transport chain function) and B) citrate synthase enzyme activity (an indicator of mitochondrial mass) in the pancreas of saline- and nicotine-
exposed offspring at 3, 15 and 26 weeks of age. All data are presented as mean6SEM. Values with an asterisk are significantly (p,0.05) different from
saline controls.
doi:10.1371/journal.pone.0003371.g004
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cells, which comprise approximately 1% of the adult rodent
pancreas [14]. Beta cells are known to be particularly susceptible
to ROS damage since they have relatively low expression of
antioxidant enzymes [38,39]. We observed dramatic mitochon-
drial structural abnormalities by electron microscopy in the beta
cells of nicotine-exposed offspring as early as 3 weeks of age. On
the contrary, loss of respiratory enzyme activity measured in the
whole pancreas was not detectable until 26 weeks. Therefore, it is
possible that whole tissue measurements were simply not sensitive
enough to detect differences between saline and nicotine exposure
at the level of the beta cell in the younger animals. We propose
that as the damage to mitochondrial protein accumulates with age,
these changes become detectable at the whole tissue level.
Based on the numerous mitochondrial defects observed in this
study (both structural and functional), it was expected that the
nicotine-exposed offspring in this animal model would have
altered beta cell function. As anticipated, developmental nicotine
exposure resulted in altered insulin granule morphology and
impaired GSIS compared to saline controls at 26 weeks of age.
Electron microscopy (EM) analysis revealed a reduction in the
total number of insulin granules within beta cells of nicotine-
exposed offspring. Furthermore, there was a pronounced reduc-
tion (18-fold) in the number of pale, immature secretory granules
by 26 weeks, suggesting that proinsulin biosynthesis may be
impaired in this animal model and thus contribute to the loss of
beta cell function. Indeed, proinsulin gene transcription has been
previously shown to be crucial for maintaining proinsulin
biosynthesis, retaining islet insulin stores, and ultimately regulating
glucose homeostasis [40]. However, this finding of fewer immature
insulin granules conflicts with EM studies in other animal models
of dysglycemia, which have reported increased numbers of
Figure 5. Insulin granule patterns during postnatal development. The number per beta cell area of: A) total insulin granules (filled, immature
and empty); B) immature insulin secretory granules (containing pale-staining proinsulin); and C) filled insulin granules (containing dense-core mature
insulin). D) Representative electron microscopy photographs of saline and nicotine-exposed beta cells at 26 weeks of age illustrate both the typical
insulin granule patterns (immature insulin granules are indicated by solid black arrows and mature insulin granules by striped arrows), and
mitochondrial structures (indicated by white boxes); N=nucleus. All data are presented as mean6SEM. Values with an asterisk are significantly
(p,0.05) different from saline controls.
doi:10.1371/journal.pone.0003371.g005
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the profound alterations in mitochondrial structure observed in
our model relative to previous studies. For example, in other
models where the number of immature secretory granules was
increased, no changes in mitochondrial structure were reported
[41,42]. In contrast, a significant proportion of the mitochondria
in nicotine-exposed offspring were visibly swollen and vacuolated
(stage 3–5) by 15 (20%) and 26 (56%) weeks of age. Another major
difference between our animal model and the Zucker fa/fa rat
model is that in Zucker fa/fa rats beta cells with a high proportion
of immature granules had increased sensitivity to glucose, suggesting
that the beta cells in this animal model are hyperactive [42]. In
contrast, the nicotine-exposed rats in this animal model of
dysglycemia exhibited a diminished ability to secrete insulin in
response to a glucose stimulus. Similarly, transgenic mice with beta
cell-specific mitochondrial defects have decreased GSIS (i.e.
impaired beta cell function) [43,44]. Therefore, the impaired
GSIS observed in this study may be attributed to the inability of
damaged mitochondria to: a) regulate proinsulin biosynthesis, and
b) couple a glucose stimulus to insulin synthesis and exocytosis.
In conclusion, data from this study indicate that fetal and
neonatal nicotine exposure adversely affects postnatal mitochon-
drial structure and function, which in turn leads to impaired beta
cell function and dysglycemia in adult offspring. These data
suggest a mechanism to explain, in part, the increased risk of type
2 diabetes in children born to women who smoked during
pregnancy. This study also provides further support to the recent
concerns about the safety of nicotine replacement therapy during
pregnancy and lactation [45].
Acknowledgments
We would like to thank the staff of the McMaster University Central
Animal Facility, Ms Jillian Hyslop and Ms Lisa Kellenberger for their
assistance with the animal work and the staff of the McMaster University
Electron Microscopy Facility for their excellent technical support with the
EM analysis.
Author Contributions
Conceived and designed the experiments: JEB MAP KMM HCG ACH.
Performed the experiments: JEB MAP ACH. Analyzed the data: JEB
ACH. Contributed reagents/materials/analysis tools: JEB SR ACH.
Wrote the paper: JEB ACH. Edited the manuscript: JEB MAP SR
KMM HCG ACH. Revised the manuscript: JEB.
References
1. Andres RL, Day MC (2000) Perinatal complications associated with maternal
tobacco use. Semin Neonatol 5: 231–241.
2. Cnattingius S, Lambe M (2002) Trends in smoking and overweight during
pregnancy: prevalence, risks of pregnancy complications, and adverse pregnancy
outcomes. Semin Perinatol 26: 286–295.
3. Faiz AS, Ananth CV (2003) Etiology and risk factors for placenta previa: an
overview and meta-analysis of observational studies. J Matern Fetal Neonatal
Med 13: 175–190.
4. Nordentoft M, Lou HC, Hansen D, Nim J, Pryds O, et al. (1996) Intrauterine
growth retardation and premature delivery: the influence of maternal smoking
and psychosocial factors. Am J Public Health 86: 347–354.
5. Robinson JS, Moore VM, Owens JA, McMillen IC (2000) Origins of fetal
growth restriction. Eur J Obstet Gynecol Reprod Biol 92: 13–19.
6. Shiverick KT, Salafia C (1999) Cigarette smoking and pregnancy I: ovarian,
uterine and placental effects. Placenta 20: 265–272.
7. Bergmann KE, Bergmann RL, Von KR, Bohm O, Richter R, et al. (2003) Early
determinants of childhood overweight and adiposity in a birth cohort study: role
of breast-feeding. Int J Obes Relat Metab Disord 27: 162–172.
8. Montgomery SM, Ekbom A (2002) Smoking during pregnancy and diabetes
mellitus in a British longitudinal birth cohort. BMJ 324: 26–27.
9. Power C, Jefferis BJ (2002) Fetal environment and subsequent obesity: a study of
maternal smoking. Int J Epidemiol 31: 413–419.
10. Toschke AM, Koletzko B, Slikker W Jr, Hermann M, Von KR (2002)
Childhood obesity is associated with maternal smoking in pregnancy.
Eur J Pediatr 161: 445–448.
11. Vik T, Jacobsen G, Vatten L, Bakketeig LS (1996) Pre- and post-natal growth in
children of women who smoked in pregnancy. Early Hum Dev 45: 245–255.
12. Von KR, Toschke AM, Koletzko B, Slikker W Jr (2002) Maternal smoking
during pregnancy and childhood obesity. Am J Epidemiol 156: 954–961.
13. Wideroe M, Vik T, Jacobsen G, Bakketeig LS (2003) Does maternal smoking
during pregnancy cause childhood overweight? Paediatr Perinat Epidemiol 17:
171–179.
14. Bruin JE, Kellenberger LD, Gerstein HC, Morrison KM, Holloway AC (2007)
Fetal and neonatal nicotine exposure and postnatal glucose homeostasis:
identifying critical windows of exposure. J Endocrinol 194: 171–178.
15. Holloway AC, Lim GE, Petrik JJ, Foster WG, Morrison KM, et al. (2005) Fetal
and neonatal exposure to nicotine in Wistar rats results in increased beta cell
apoptosis at birth and postnatal endocrine and metabolic changes associated
with type 2 diabetes. Diabetologia 48: 2661–2666.
16. Ontario Medical Association (1999) Rethinking stop-smoking medications:
myths and facts.
17. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, et al. (2003) Beta-cell
deficit and increased beta-cell apoptosis in humans with type 2 diabetes.
Diabetes 52: 102–110.
Figure 6. Oxidative stress at 26 weeks of age. Reactive oxygen
species (ROS) production and the incidence of protein carbonyl groups
(an indication of oxidative damage to protein) in islets isolated from the
pancreas of saline- (white bar) and nicotine-exposed (black bar)
offspring at 26 weeks of age. All data are expressed as a percentage
of the average saline control value and are presented as the
mean6SEM. Values with an asterisk are significantly (p,0.05) different
from saline controls.
doi:10.1371/journal.pone.0003371.g006
Figure 7. Glucose-stimulated insulin secretion at 26 weeks of
age. Insulin release into the media was measured following glucose
stimulation (16.7 mM; white bars) or basal glucose exposure (3.0 mM;
striped bars) in saline- and nicotine-expose offspring at 26 weeks of
age. All data are expressed as the insulin concentration normalized to
the insulin concentration under basal glucose conditions (3.0 mM).
Values with an asterisk indicate a significant difference in the
stimulated/basal insulin release ratio for saline versus nicotine exposure
(p,0.05). All data are presented as mean6SEM.
doi:10.1371/journal.pone.0003371.g007
Nicotine and the Mitochondria
PLoS ONE | www.plosone.org 9 October 2008 | Volume 3 | Issue 10 | e337118. Marchetti P, Del PS, Lupi R, Del GS (2006) The pancreatic beta-cell in human
Type 2 diabetes. Nutr Metab Cardiovasc Dis 16 Suppl 1: S3–S6.
19. Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative
diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet
39: 359–407.
20. Green DR, Kroemer G (2004) The pathophysiology of mitochondrial cell death.
Science 305: 626–629.
21. Bruin JE, Petre MA, Lehman MA, Raha S, Gerstein HC, et al. (2008) Maternal
nicotine exposure increases oxidative stress in the offspring. Free Radic Biol Med
44: 1919–1925.
22. Bruin JE, Gerstein HC, Morrison KM, Holloway AC (2008) Increased
pancreatic beta cell apoptosis following fetal and neonatal exposure to nicotine
is mediated via the mitochondria. Toxicol Sci 103: 362–370.
23. Maechler P, de Andrade PB (2006) Mitochondrial damages and the regulation
of insulin secretion. Biochem Soc Trans 34: 824–827.
24. Lowell BB, Shulman GI (2005) Mitochondrial dysfunction and type 2 diabetes.
Science 307: 384–387.
25. MacDonald PE, Joseph JW, Rorsman P (2005) Glucose-sensing mechanisms in
pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci 360: 2211–2225.
26. Anello M, Lupi R, Spampinato D, Piro S, Masini M, et al. (2005) Functional and
morphological alterations of mitochondria in pancreatic beta cells from type 2
diabetic patients. Diabetologia 48: 282–289.
27. Simmons RA, Suponitsky-Kroyter I, Selak MA (2005) Progressive accumulation
of mitochondrial DNA mutations and decline in mitochondrial function lead to
beta-cell failure. J Biol Chem 280: 28785–28791.
28. Holloway AC, Kellenberger LD, Petrik JJ (2006) Fetal and neonatal exposure to
nicotine disrupts ovarian function and fertility in adult female rats. Endocrine
30: 213–216.
29. Sun MG, Williams J, Munoz-Pinedo C, Perkins GA, Brown JM, et al. (2007)
Correlated three-dimensional light and electron microscopy reveals transforma-
tion of mitochondria during apoptosis. Nat Cell Biol 9: 1057–1065.
30. Parise G, Phillips SM, Kaczor JJ, Tarnopolsky MA (2005) Antioxidant enzyme
activity is up-regulated after unilateral resistance exercise training in older adults.
Free Radic Biol Med 39: 289–295.
31. Maechler P, Carobbio S, Rubi B (2006) In beta-cells, mitochondria integrate
and generate metabolic signals controlling insulin secretion. Int J Biochem Cell
Biol 38: 696–709.
32. Simmons RA (2006) Developmental origins of diabetes: the role of oxidative
stress. Free Radic Biol Med 40: 917–922.
33. Wetscher GJ, Bagchi M, Bagchi D, Perdikis G, Hinder PR, et al. (1995) Free
radical production in nicotine treated pancreatic tissue. Free Radic Biol Med 18:
877–882.
34. Ozokutan BH, Ozkan KU, Sari I, Inanc F, Guldur ME, et al. (2005) Effects of
maternal nicotine exposure during lactation on breast-fed rat pups. Biol Neonate
88: 113–117.
35. Husain K, Scott BR, Reddy SK, Somani SM (2001) Chronic ethanol and
nicotine interaction on rat tissue antioxidant defense system. Alcohol 25: 89–97.
36. Kim WH, Lee JW, Suh YH, Hong SH, Choi JS, et al. (2005) Exposure to
chronic high glucose induces beta-cell apoptosis through decreased interaction of
glucokinase with mitochondria: downregulation of glucokinase in pancreatic
beta-cells. Diabetes 54: 2602–2611.
37. Tang C, Han P, Oprescu AI, Lee SC, Gyulkhandanyan AV, et al. (2007)
Evidence for a role of superoxide generation in glucose-induced beta-cell
dysfunction in vivo. Diabetes 56: 2722–2731.
38. Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene
expression in pancreatic islets compared with various other mouse tissues. Free
Radic Biol Med 20: 463–466.
39. Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant
enzyme gene expression and antioxidative defense status of insulin-producing
cells. Diabetes 46: 1733–1742.
40. Leibowitz G, Uckaya G, Oprescu AI, Cerasi E, Gross DJ, et al. (2002) Glucose-
regulated proinsulin gene expression is required for adequate insulin production
during chronic glucose exposure. Endocrinology 143: 3214–3220.
41. Momose K, Nunomiya S, Nakata M, Yada T, Kikuchi M, et al. (2006)
Immunohistochemical and electron-microscopic observation of beta-cells in
pancreatic islets of spontaneously diabetic Goto-Kakizaki rats. Med Mol
Morphol 39: 146–153.
42. Chan CB, Wright GM, Wadowska DW, MacPhail RM, Ireland WP, et al.
(1998) Ultrastructural and secretory heterogeneity of fa/fa (Zucker) rat islets.
Mol Cell Endocrinol 136: 119–129.
43. Silva JP, Kohler M, Graff C, Oldfors A, Magnuson MA, et al. (2000) Impaired
insulin secretion and beta-cell loss in tissue-specific knockout mice with
mitochondrial diabetes. Nat Genet 26: 336–340.
44. Silva JP, Larsson NG (2002) Manipulation of mitochondrial DNA gene
expression in the mouse. Biochim Biophys Acta 1555: 106–110.
45. Ginzel KH, Maritz GS, Marks DF, Neuberger M, Pauly JR, et al. (2007) Critical
review: nicotine for the fetus, the infant and the adolescent? J Health Psychol 12:
215–224.
Nicotine and the Mitochondria
PLoS ONE | www.plosone.org 10 October 2008 | Volume 3 | Issue 10 | e3371